Mkts

Chemomab Therapeutics Ltd.

NASDAQ: CMMB
$1.55-0.09 (-5.49%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
1.451.70
52-week range
0.922.99
Today
Open1.70
Previous close1.55
Volume—
Valuation
Market cap11.88M
P/E ratio—
EPS (TTM)-0.01
Income & risk
Dividend / yield—
Beta0.74
Avg volume95.0K
Discussion

CMMB News

Stories mentioning CMMB from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ4 '25Dec 31Q4 '24Dec 31Q4 '23Dec 31Q1 '23Mar 31Q4 '22Dec 31Q3 '22Sep 30Q2 '22Jun 30Q1 '22Mar 31
Income Statement
Revenue
Cost of Goods Sold
Gross Profit(2,326)(2,465)(4,393)0.00(5,142)0.000.000.00
Operating Expenses
Research & Development(9,391)(3,897)3,1576,8875,8955,4232,9142,745
Sales General & Admin
Total Operating Expenses(14,053)(8,881)1,8399,0498,6428,3176,2545,320
Operating Income (Loss)
Interest Income
Interest Expense
Other Expense
Pretax Income14,5519,601(675.00)(8,732)(8,262)(8,080)(6,734)(5,104)
Tax Provision523.00523.00523.0021.0010.000.00(544.00)0.00
Net Income (Loss)14,0289,078(1,198)(8,753)(8,272)(8,080)(6,190)(5,104)
Earnings Per Share (Basic)0.030.03(0.01)0.04(0.04)0.040.030.02
Earnings Per Share (Diluted)0.030.03(0.01)0.04(0.04)0.040.030.02
Weighted Average Shares Outstanding (Basic)510,228359,049234,999220,996227,589228,773228,173228,090
Weighted Average Shares Outstanding (Diluted)510,228359,049234,999220,996227,589228,773228,173228,090

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CMMB

Chemomab Therapeutics Ltd. (NASDAQ: CMMB) is a stock listed on the Nasdaq Stock Market under the ticker symbol CMMB. It last traded at $1.55 (Nov 18, 2026, 4:00 PM ET), down 5.5% on the day. That gives Chemomab Therapeutics a market capitalisation of $11.9M.

Over the past 52 weeks CMMB has traded between $0.9200 and $2.99.

Net income for the quarter ended Dec 31, 2025 was $14.0M.

Last 4 quarters
Quarter endedRevenueNet income
Dec 31, 2025—$14.0M
Dec 31, 2024—$9.1M
Dec 31, 2023—-$1.2M
Mar 31, 2023—-$8.8M

From Chemomab Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…